AdvaMed
AdvaMed, or the Advanced Medical Technology Association, is a medical device trade association, based in Washington, D.C. Its members are medical technology companies (medical devices, diagnostic products, and health information systems) that collectively represents 80% of U.S. medical technology firms in the United States, that produce close to 90% of annual health care technology purchases in the United States and more than 40% globally.[1]
Stephen J. Ubl is AdvaMed’s President and CEO,[2] and its Board Chairman is David C. Dvorak, who also serves as President and CEO of Zimmer Holdings.[3]
Matthew Wetzel was appointed vice president and assistant general counsel on September 11, 2015.[4]
Policies
AdvaMed advocates for a legal, regulatory, and economic climate that advances global health care by assuring patients can have access to the benefits of medical technology.[5] In 2010, AdvaMed's Ubl "called for the creation of a new White House office dedicated to promoting U.S. innovation" as well as a requirement that federal agencies "provide an innovation impact statement for all major policy decisions or regulations".[6] In 2006 AdvaMed launched a $1 million "education and advertising campaign designed to convey the value of medical technology to both policy makers and the general public in Washington, D.C."[7]
AdvaMed supports the repeal of the Affordable Care Act’s tax on medical devices.[8][9] According to a study commissioned by AdvaMed, the tax has led to a "dramatic increase in insurance company strategies curtailing the use of newer technologies" such as "pay-for-performance, risk-sharing, and the use of evidence-based medicine, which can lead to newer devices not being covered by insurance if there’s no proof they are better than older devices". Sixty-two percent of companies in the study saw the use of such payment strategies in 2014.[10]
See also
- Biotechnology Industry Organization (BIO)
- Pharmaceutical Research and Manufacturers of America (PhRMA)
References
- ^ "About AdvaMed". AdvaMed. Retrieved 4 November 2014.
- ^ Fenske, Sean (November 2007). "An interview with Stephen J. Ubl, President and CEO of AdvaMed". BNet.
- ^ "Zimmer CEO David Dvorak named new chairman of AdvaMed". Mass Device. 2012-03-14.
- ^ "AdvaMed snags Boston Scientific's Wetzel for assistant GC". Mass Device. 2015-09-11.
- ^ Lee, Jaimy (2010-11-23). "AdvaMed focuses on innovation in new campaign". PR Week.
- ^ Pecquet, Julian (10 June 2010). "Healthcare industry fights for White House role in innovation". The Hill.
- ^ "AdvaMed Publicity Campaign Promotes Value of Medical Technology". Medical Device and Diagnostic Industry. 1 June 2006.
- ^ Ubl, Stephen J. (7 June 2013). "Repeal the medical device tax". The Hill.
- ^ "Medical Device Tax". AdvaMed. Retrieved 4 November 2014.
- ^ Japsen, Bruce (6 October 2014). "How Insurers Curb Costly Hips, Knees And Other Medical Devices". Forbes.